Physician profile

Rajesh Rao

Pulmonary Disease · Auburn, NY

NPI 1528060472

$18,728.44

in general payments reported to CMS, 2019-2025

48 companies · $2,047 in 2025

The $2,047 reported for 2025 was more than what 76% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

See the full distribution for Pulmonary Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,897.25
Travel and Lodging$2,961.01
Education$32.48

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medical Device Business Services, INC. $2,092.35 2023 Na
Veran Medical Technologies, INC. $1,985.34 2019-2020
Noah Medical Corporation $1,633.25 2024-2025 Galaxy
Glaxosmithkline, LLC. $1,594.21 2019-2025 Nucala, Trelegy Ellipta
Inspire Medical Systems, INC. $1,559.87 2021
Pinnacle Biologics, INC $1,472.43 2021-2022
Astrazeneca Pharmaceuticals LP $1,112.40 2019-2025 Fasenra, Symbicort, Breztri
Ethicon INC. $1,052.11 2021-2024 Monarch Platform
Novartis Pharmaceuticals Corporation $509.77 2019-2024
Actelion Pharmaceuticals US, INC. $475.33 2019-2023 Uptravi, Opsumit
Regeneron Healthcare Solutions, INC. $470.45 2022-2025 Dupixent
Philips North America LLC $425.75 2019-2023
Boehringer Ingelheim Pharmaceuticals, INC. $411.02 2019-2025 Ofev, Spiriva Respimat, Stiolto Respimat
Takeda Pharmaceuticals U.S.A., INC. $329.30 2021-2025 Glassia
Genzyme Corporation $305.08 2021-2025
Show all 48 companies
CompanyGeneral paymentsYearsTop products
Olympus Corporation of The Americas $290.10 2019-2022
Janssen Pharmaceuticals, INC $230.78 2019-2023 Xarelto
Mylan Specialty L.P. $226.67 2022-2024 Yupelri, Yupelri
Amgen INC. $221.55 2022-2025 Tezspire
Insmed, INC. $213.11 2022-2025 Arikayce
Electromed, INC. $182.59 2023-2025 Smartvest
Abbvie INC. $179.02 2023-2024
Harmony Biosciences LLC $165.79 2020-2025
Alexion Pharmaceuticals, INC. $165.47 2022
Grifols USA, LLC $145.64 2022-2025 Prolastin-C Liquid
Olympus America INC. $131.14 2023 Always-On Tip Tracked Forceps, 1.8mm Od, Serrated Cup, Spin Vision Scope, 4.0mm Od, 2.0mm Wc, Spin Perc Localization Needle 19ga X 105mm, 1cm Marking Zone
Jazz Pharmaceuticals INC. $118.43 2019
Intuitive Surgical, INC. $117.40 2025
Baxter Healthcare $96.07 2022-2023 Hillrom - Life 2000 Ventilation System
Mauna Kea Technologies, INC. $95.52 2021
Verona Pharma, INC. $85.81 2025 Ohtuvayre
Merck Sharp & Dohme LLC $78.71 2023-2025 Verquvo, Capvaxive
Sunovion Pharmaceuticals INC. $65.76 2019
Itamar Medical INC $65.69 2023-2024 Watchpatone
Pfizer INC. $48.74 2021-2022
Avadel Cns Pharmaceuticals, LLC $48.36 2024-2025 Lumryz
Inogen, INC. $47.23 2023 Inogen One G5 Oxygen Concentrator - Bluetooth
Genentech USA, INC. $43.35 2021-2023 Xolair
Fisher & Paykel Healthcare INC $40.99 2024 Fisher & Paykel Healthcare
Pulmonx Corporation $36.18 2021
United Therapeutics Corporation $31.07 2021
Resmed Corp $25.68 2019
Ani Pharmaceuticals, INC. $23.56 2025 Purified Cortrophin Gel
Monaghan Medical Corporation $22.30 2021-2022
Vifor Pharma, INC. $20.87 2025 Zemaira
Tactile Systems Technology INC $17.60 2022
Apria Healthcare LLC $16.66 2021
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $1.94 2025 Lifevest

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Rajesh Rao

$18,728.44

in general payments reported 2019-2025

Years
2019-2025
Top company
Medical Device Business Services, INC.
Context
The $2,047 reported for 2025 was more than what 76% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/295790/rajesh-rao

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.